Literature DB >> 6314174

The use of cyproheptadine (peritol) as a drug blocking corticotropin secretion in the treatment of Itsenko-Cushing's disease.

I V Komissarenko, A K Cheban, S I Rybakov, V I Slavnov, E V Luchitskii.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6314174     DOI： 10.1007/bf01186865

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN： 0097-0549


× No keyword cloud information.
  6 in total

1.  The role of dopaminergic depletion in the pathogenesis of Cushing's disease and the possible consequences for medical therapy.

Authors:  S W Lamberts; H A Timmermans; F H De Jong; J C Birkenhager
Journal:  Clin Endocrinol (Oxf)       Date:  1977-09       Impact factor: 3.478

2.  [Effect of large doses of reserpine on the hypothalamo-hypophyseal-adrenal system in Itsenko-Cushing's disease].

Authors:  E I Marova; S A Butrova; G S Kolesnikova
Journal:  Probl Endokrinol (Mosk)       Date:  1978 Mar-Apr

3.  [Preliminary results of treatment of Cushing's syndrome with cyproheptadine].

Authors:  W Hartwig; A Kasperlik-Załuska; B Migdalska; J Wilczyńska; T Wiśniewska-Woźniak; J Załuska
Journal:  Endokrynol Pol       Date:  1979 Mar-Apr       Impact factor: 1.582

Review 4.  The central nervous system and Cushing's syndrome.

Authors:  D T Krieger
Journal:  Mt Sinai J Med       Date:  1972 Sep-Oct

5.  Cyproheptadine and Cushing's disease.

Authors:  A W Burrows; C W Burke; L H Rees
Journal:  Br Med J       Date:  1977-04-23

6.  Cyproheptadine-induced remission of Cushing's disease.

Authors:  D T Krieger; L Amorosa; F Linick
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.